Infanrix Hexa |
Human |
diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) and Haemophilus influenzae type-b (Hib) conjugate vaccine (adsorbed) |
Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin);hepatitis B surface antigen;poliovirus (inactivated) (type-1 (Mahoney strain), type-2 (MEF-1 strain), type-3 (Saukett strain));Haemophilus influenzae type b polysaccharide |
EMEA/H/C/000296 |
GlaxoSmithKline Biologicals S.A. |
2000/10/23
|
Authorised |
Infanrix Penta |
Human |
diphtheria (D), tetanus (T), pertussis (acellular, component) (Pa), hepatitis B (rDNA) (HBV), poliomyelitis (inactivated) (IPV) vaccine (adsorbed) |
Diphtheria toxoid;tetanus toxoid;Bordetella pertussis antigens (pertussis toxoid, filamentous haemagglutinin, pertactin);poliovirus (inactivated) (type 1 (Mahoney strain), type 2 (MEF-1 strain), type 3 (Saukett strain));hepatitis B surface antigen |
EMEA/H/C/000295 |
GlaxoSmithKline Biologicals S.A. |
2000/10/23
|
Lapsed |
Hexavac |
Human |
diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis B (recombinant) and Haemophilus influenzae type b conjugate vaccine, adjuvanted |
purified diphtheria toxoid;Purified Tetanus Toxoid;purified pertussis toxoid;purified pertussis filamentous haemagglutinin;hepatitis B surface antigen;Inactivated Type 1 Poliovirus (Mahoney);inactivated type 2 poliovirus (MEF 1);Inactivated Type 3 Poliovirus (Saukett);Haemophilus influenzae type b polysaccharide |
EMEA/H/C/000298 |
Sanofi Pasteur MSD, SNC |
2000/10/23
|
Withdrawn |
Agenerase |
Human |
amprenavir |
amprenavir |
EMEA/H/C/000264 |
Glaxo Group Ltd. |
2000/10/20
|
Withdrawn |
Actos |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/000285 |
CHEPLAPHARM Arzneimittel GmbH |
2000/10/13
|
Authorised |
Glustin |
Human |
pioglitazone |
pioglitazone hydrochloride |
EMEA/H/C/000286 |
Takeda Pharma A/S |
2000/10/11
|
Withdrawn |
Panretin |
Human |
alitretinoin |
alitretinoin |
EMEA/H/C/000279 |
Eisai GmbH |
2000/10/11
|
Withdrawn |
Keppra |
Human |
levetiracetam |
levetiracetam |
EMEA/H/C/000277 |
UCB Pharma SA |
2000/09/29
|
Authorised |
Herceptin |
Human |
trastuzumab |
trastuzumab |
EMEA/H/C/000278 |
Roche Registration GmbH |
2000/08/28
|
Authorised |
Kogenate Bayer |
Human |
octocog alfa |
Octocog alfa |
EMEA/H/C/000275 |
Bayer AG |
2000/08/04
|
Lapsed |
Helixate NexGen |
Human |
octocog alfa |
Octocog alfa |
EMEA/H/C/000276 |
Bayer AG |
2000/08/04
|
Withdrawn |
Hepacare |
Human |
hepatitis B surface antigens recombinant (S, pre-S1, pre-S2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (C127I) cells] |
hepatitis B surface antigens recombinant (S, pre-S1, pre-S2) adsorbed on aluminium hydroxide [produced on genetically engineered murine (C127I) cells] |
EMEA/H/C/000261 |
Evans Vaccines Ltd. |
2000/08/04
|
Withdrawn |
NovoMix |
Human |
insulin aspart |
insulin aspart |
EMEA/H/C/000308 |
Novo Nordisk A/S |
2000/08/01
|
Authorised |
DaTSCAN |
Human |
ioflupane (123l) |
ioflupane (123l) |
EMEA/H/C/000266 |
GE Healthcare B.V. |
2000/07/27
|
Authorised |
Visudyne |
Human |
verteporfin |
verteporfin |
EMEA/H/C/000305 |
CHEPLAPHARM Arzneimittel GmbH |
2000/07/27
|
Authorised |
Myocet liposomal (previously Myocet) |
Human |
doxorubicin |
doxorubicin hydrochloride |
EMEA/H/C/000297 |
CHEPLAPHARM Arzneimittel GmbH |
2000/07/13
|
Authorised |
Avandia |
Human |
rosiglitazone |
rosiglitazone |
EMEA/H/C/000268 |
SmithKline Beecham Plc |
2000/07/11
|
Expired |
Venvia |
Human |
rosiglitazone |
rosiglitazone |
EMEA/H/C/000270 |
SmithKline Beecham Plc |
2000/07/11
|
Withdrawn |
Nyracta |
Human |
rosiglitazone |
rosiglitazone |
EMEA/H/C/000269 |
SmithKline Beecham Plc |
2000/07/11
|
Withdrawn |
Toujeo (previously Optisulin) |
Human |
insulin glargine |
insulin glargine |
EMEA/H/C/000309 |
Sanofi-aventis Deutschland GmbH |
2000/06/26
|
Authorised |